These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8960523)

  • 41. Dose rate table for a 32P intravascular brachytherapy source from Monte Carlo calculations.
    Bohm TD; Mourtada FA; Das RK
    Med Phys; 2001 Aug; 28(8):1770-5. PubMed ID: 11548948
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Theoretical assessment of late cardiac complication from endovascular brachytherapy for restenosis prevention.
    Giap H; Massullo V; Teirstein P; Tripuraneni P
    Cardiovasc Radiat Med; 1999; 1(3):233-8. PubMed ID: 11272367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monte Carlo characterization of a 32P source for intravascular brachytherapy.
    Wang R; Li XA
    Med Phys; 2001 Aug; 28(8):1776-85. PubMed ID: 11548949
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Self-absorption correction for 32P, 198Au and 188Re stents: dose point kernel calculations versus Monte Carlo.
    Reynaert N; Häfeli UO
    Med Phys; 2001 Sep; 28(9):1883-97. PubMed ID: 11585219
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dosimetric effect of source centering and residual plaque for beta-emitting catheter based intravascular brachytherapy sources.
    Sehgal V; Li Z; Palta JR; Bolch WE
    Med Phys; 2001 Oct; 28(10):2162-71. PubMed ID: 11695779
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimal source position for irradiation of coronary bifurcations in endovascular brachytherapy with catheter based beta or iridium-192 sources.
    Marijnissen JP; Coen VL; van der Giessen WJ; de Pan C; Serruys PW; Levendag PC
    Radiother Oncol; 2004 Apr; 71(1):99-108. PubMed ID: 15066302
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intracoronary irradiation markedly reduces restenosis after balloon angioplasty in a porcine model.
    Wiedermann JG; Marboe C; Amols H; Schwartz A; Weinberger J
    J Am Coll Cardiol; 1994 May; 23(6):1491-8. PubMed ID: 8176112
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravascular brachytherapy to prevent restenosis: dosimetric considerations.
    Campos L; Stabin M
    Cell Mol Biol (Noisy-le-grand); 2002 Jul; 48(5):429-39. PubMed ID: 12146694
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dosimetry characterization of a 32P source wire used for intravascular brachytherapy with automated stepping.
    Mourtada F; Soares CG; Seltzer SM; Bergstrom PM; Fernández-Verea JM; Asenjo J; Lott SH
    Med Phys; 2003 May; 30(5):959-71. PubMed ID: 12773005
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dosimetric characteristics of a new 125I brachytherapy source.
    Gearheart DM; Drogin A; Sowards K; Meigooni AS; Ibbott GS
    Med Phys; 2000 Oct; 27(10):2278-85. PubMed ID: 11099194
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intracoronary irradiation: dose response for the prevention of restenosis in swine.
    Weinberger J; Amols H; Ennis RD; Schwartz A; Wiedermann JG; Marboe C
    Int J Radiat Oncol Biol Phys; 1996 Nov; 36(4):767-75. PubMed ID: 8960502
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monte Carlo calculations and experimental measurements of the TG-43U1-recommended dosimetric parameters of 125I (Model IR-Seed2) brachytherapy source.
    Sheikholeslami S; Nedaie HA; Sadeghi M; Pourbeigy H; Shahzadi S; Zehtabian M; Hasani M; Meigooni AS
    J Appl Clin Med Phys; 2016 Jul; 17(4):430-441. PubMed ID: 27455485
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A BrachyPhantom for verification of dose calculation of HDR brachytherapy planning system.
    Austerlitz C; Campos CA
    Med Phys; 2013 Nov; 40(11):112103. PubMed ID: 24320456
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of 132 Ir sources for brachytherapy.
    Kato H; Kogure H; Takeuchi N; Kobayashi K; Suzuki K; Shikata E
    Radioisotopes; 1980 Sep; 29(9):427-31. PubMed ID: 7221020
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pure beta-particle-emitting stents inhibit neointima formation in rabbits.
    Hehrlein C; Stintz M; Kinscherf R; Schlösser K; Huttel E; Friedrich L; Fehsenfeld P; Kübler W
    Circulation; 1996 Feb; 93(4):641-5. PubMed ID: 8640989
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel system for intracoronary beta-irradiation: description and dosimetric results.
    Popowski Y; Verin V; Schwager M; Nouet P; Papirov I; Rouzaud M; Urban P; Landis JR; Rutishauser W; Kurtz JM
    Int J Radiat Oncol Biol Phys; 1996 Nov; 36(4):923-31. PubMed ID: 8960522
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radial dose distribution of 192Ir and 137Cs seed sources.
    Thomason C; Higgins P
    Med Phys; 1989; 16(2):254-7. PubMed ID: 2716705
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of the surface radiation dose and dose gradient in early stage breast cancer using high-dose-rate brachytherapy MammoSite applicator.
    Sadeghi A; Prestidge B; Lee JM; Rosenthal A
    Brachytherapy; 2006; 5(4):230-4. PubMed ID: 17118315
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dose distribution for a 32P-impregnated coronary stent: comparison of theoretical calculations and measurements with radiochromic film.
    Duggan DM; Coffey CW; Levit S
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):713-20. PubMed ID: 9486624
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Dosimetry fundamentals of endovascular therapy using Re-188 for the prevention of restenosis after angioplasty].
    Kotzerke J; Rentschler M; Glatting G; Schneider E; Stabin M; Knapp FF; Reske SN
    Nuklearmedizin; 1998 Mar; 37(2):68-72. PubMed ID: 9547753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.